2021 NIDA International Forum: Speaker Presentations

If you would like to view the recordings of the 2021 plenary sessions, you may click the session recording links below.

If you would like to view these the speaker presentations, you may click on any of the presentation links below to request a copy via email.

Tuesday, June 22, 2021

  • Tuesday Plenary Session Recording

NIDA Support to Develop the Addiction Research Workforce

Global Impact of COVID-19 on Substance Use

  • Trendspotter Data From Europe
    Paul Griffiths, European Monitoring Centre for Drugs and Drug Addiction
  • Results From the Global Study of Stress and Resilience in the Face of COVID-19
    Mustafa al’Absi, University of Minnesota Medical School Duluth Global Health Research Institute

Wednesday, June 23, 2021

  • Wednesday Plenary Session Recording

UNODC/WHO International Standards for the Treatment of Drug Use Disorders

UNODC/WHO Programme on Drug Dependence Treatment and Care and Development of the International Standards for the Treatment of Drug Use Disorders
Anja Busse, UNODC

Field Testing (of the International Standards) in Indonesia
Eva Suryani, Atma Jaya Catholic University of Indonesia and Kristiana Siste, Universitas Indonesia—Cipto Mangunkusumo General Hospital, Indonesia

Field Testing (of the International Standards) In Chile
Carlos Ibáñez, Universidad de Chile

Content and Implementation of the International Standards for the Treatment of Drug Use Disorders (2020)
Wataru Kashino, UNODC

Quality Assurance in Nigeria
Auwal Salihu, Aminu Kano Teaching Hospital, Nigeria

Quality Assurance in Pakistan
Sabino Sikandar Jalal, Senior Joint Secretary, Ministry of Narcotics Control, Government of Pakistan

Community-Based Outreach: UNODC/WHO Stop-Overdose-Safely (S-O-S) Project Implementation in Kazakhstan, Kyrgyzstan, Tajikistan, and Ukraine
Paul Dietze, Burnet Institute, Australia

Populations With Special Treatment and Care Needs: Substance Use Management During Pregnancy— Capacity Building for Health Professionals
Marta Torrens, Institut de Neuropsiquiatria i Addiccions Parc de Salut Mar Universitat Autònoma de Barcelona, Spain

Thursday, June 24, 2021

  • Thursday Plenary Session Recording

Rapid Research Reports From Around the Globe

Substance Use in Mild COVID-19 Patients: A Retrospective Study
João Maurício Castaldelli-Maia, ABC Health University Center, Brazil

Canadian Perceptions and Experiences With Virtual Services and Supports for Substance Use
Anna Goodman, Canadian Centre on Substance Use and Addiction

Changes in Illicit Drug Supply During COVID-19: Findings of a Community-Based Cohort of Women Sex Workers in Metro Vancouver, Canada
Sarah Moreheart, Simon Fraser University, Canada

Monitoring an Online Illicit Drug Market During COVID-19 in Georgia
Ada Beselia, Addiction Research Centre Alternative Georgia

Drug Use Patterns in Mexico During the COVID-19 Pandemic
Judith Ferrer Alarcón, Comisión Nacional contra las Adicciones, Mexico

Depression Among Medical and Non-Medical Students and Its Association With Cognitive Enhancers and Psychostimulants Use During COVID-19 Quarantine
Basma Damiri, An-Najah National University, Palestine

Why Are Injecting Drug Users and Patients in Methadone Substitution “Protected” From SARS COV 2 Infections? 
Adrian Abagiu, National Institute for Infectious Diseases “Prof. Dr. Matei Bals,” Romania

Examining Changes in Post-Traumatic Stress Disorder Symptoms and Substance Use Among a Sample of Canadian Veterans Working With Service Dogs: An Exploratory Longitudinal Study
Colleen Dell, University of Saskatchewan, Canada

Correlates of Marijuana Use Problems in a National Sample of Female Ecuadorian Students
Daniela Ocaña-Gordillo, Parametría Consultancy, Ecuador

Implementing and Evaluating the Universal Prevention Curriculum to Promote Capacity Building Among Drug Demand Reduction Practitioners in Nigeria: Lessons Learned and Future Directions
Martin Agwogie, Global Initiative on Substance Abuse, Nigeria

Urdu Translation and Psychometric Properties of Perceived Stigma of Substance Abuse Scale (PSAS) in Patients With Substance Use Disorders in Pakistan
Salman Shahzad, University of Karachi, Pakistan